Evidence of increased prostate cancer detection in men aged 50 to 59

A review of 324,684 biopsies performed between 1995 and 2002

Franklin C. Lowe, Scott M. Gilbert, Hillel Kahane

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives. To analyze the age-specific detection rate of prostate cancer diagnosed from 324,684 biopsies submitted to a single laboratory and to assess the degree of prostate cancer in younger men. The advent of prostate-specific antigen (PSA) testing and increased prostate cancer screening has led to increased evaluations for prostate cancer. The initial stage and age at presentation in prostate cancer has shifted. Methods. From 1995 through 2001, all prostate biopsies submitted to the laboratory were reviewed and analyzed for the diagnosis of prostate cancer, cancer detection rate, and age at diagnosis. Results. The overall detection rate of prostate cancer increased by 15% from 29% to 34% for all biopsies submitted during the study period. For the age group 50 to 59 years, a 45% increase occurred in the detection of prostate cancer from a baseline of approximately 11% in 1995 to greater than 16% in 2001. For the age group 70 to 79 years, the detection of prostate cancer decreased from a baseline of 41% in 1995 to 36% in 2001. Conclusions. The increase in prostate cancer diagnosis among younger men in the United States has been significant. The increase is likely multifactorial and may be attributable to the impact of PSA and prostate cancer screening efforts. This has led to a greater number of younger men undergoing evaluation for prostate cancer. Thus, a heightened awareness regarding the diagnosis of prostate cancer among younger men is needed.

Original languageEnglish (US)
Pages (from-to)1045-1049
Number of pages5
JournalUrology
Volume62
Issue number6
DOIs
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Biopsy
Prostate-Specific Antigen
Early Detection of Cancer
Age Groups
Prostate

ASJC Scopus subject areas

  • Urology

Cite this

Evidence of increased prostate cancer detection in men aged 50 to 59 : A review of 324,684 biopsies performed between 1995 and 2002. / Lowe, Franklin C.; Gilbert, Scott M.; Kahane, Hillel.

In: Urology, Vol. 62, No. 6, 12.2003, p. 1045-1049.

Research output: Contribution to journalArticle

@article{14935973ca0a49eb89e7b37f34349cdf,
title = "Evidence of increased prostate cancer detection in men aged 50 to 59: A review of 324,684 biopsies performed between 1995 and 2002",
abstract = "Objectives. To analyze the age-specific detection rate of prostate cancer diagnosed from 324,684 biopsies submitted to a single laboratory and to assess the degree of prostate cancer in younger men. The advent of prostate-specific antigen (PSA) testing and increased prostate cancer screening has led to increased evaluations for prostate cancer. The initial stage and age at presentation in prostate cancer has shifted. Methods. From 1995 through 2001, all prostate biopsies submitted to the laboratory were reviewed and analyzed for the diagnosis of prostate cancer, cancer detection rate, and age at diagnosis. Results. The overall detection rate of prostate cancer increased by 15{\%} from 29{\%} to 34{\%} for all biopsies submitted during the study period. For the age group 50 to 59 years, a 45{\%} increase occurred in the detection of prostate cancer from a baseline of approximately 11{\%} in 1995 to greater than 16{\%} in 2001. For the age group 70 to 79 years, the detection of prostate cancer decreased from a baseline of 41{\%} in 1995 to 36{\%} in 2001. Conclusions. The increase in prostate cancer diagnosis among younger men in the United States has been significant. The increase is likely multifactorial and may be attributable to the impact of PSA and prostate cancer screening efforts. This has led to a greater number of younger men undergoing evaluation for prostate cancer. Thus, a heightened awareness regarding the diagnosis of prostate cancer among younger men is needed.",
author = "Lowe, {Franklin C.} and Gilbert, {Scott M.} and Hillel Kahane",
year = "2003",
month = "12",
doi = "10.1016/S0090-4295(03)00782-9",
language = "English (US)",
volume = "62",
pages = "1045--1049",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Evidence of increased prostate cancer detection in men aged 50 to 59

T2 - A review of 324,684 biopsies performed between 1995 and 2002

AU - Lowe, Franklin C.

AU - Gilbert, Scott M.

AU - Kahane, Hillel

PY - 2003/12

Y1 - 2003/12

N2 - Objectives. To analyze the age-specific detection rate of prostate cancer diagnosed from 324,684 biopsies submitted to a single laboratory and to assess the degree of prostate cancer in younger men. The advent of prostate-specific antigen (PSA) testing and increased prostate cancer screening has led to increased evaluations for prostate cancer. The initial stage and age at presentation in prostate cancer has shifted. Methods. From 1995 through 2001, all prostate biopsies submitted to the laboratory were reviewed and analyzed for the diagnosis of prostate cancer, cancer detection rate, and age at diagnosis. Results. The overall detection rate of prostate cancer increased by 15% from 29% to 34% for all biopsies submitted during the study period. For the age group 50 to 59 years, a 45% increase occurred in the detection of prostate cancer from a baseline of approximately 11% in 1995 to greater than 16% in 2001. For the age group 70 to 79 years, the detection of prostate cancer decreased from a baseline of 41% in 1995 to 36% in 2001. Conclusions. The increase in prostate cancer diagnosis among younger men in the United States has been significant. The increase is likely multifactorial and may be attributable to the impact of PSA and prostate cancer screening efforts. This has led to a greater number of younger men undergoing evaluation for prostate cancer. Thus, a heightened awareness regarding the diagnosis of prostate cancer among younger men is needed.

AB - Objectives. To analyze the age-specific detection rate of prostate cancer diagnosed from 324,684 biopsies submitted to a single laboratory and to assess the degree of prostate cancer in younger men. The advent of prostate-specific antigen (PSA) testing and increased prostate cancer screening has led to increased evaluations for prostate cancer. The initial stage and age at presentation in prostate cancer has shifted. Methods. From 1995 through 2001, all prostate biopsies submitted to the laboratory were reviewed and analyzed for the diagnosis of prostate cancer, cancer detection rate, and age at diagnosis. Results. The overall detection rate of prostate cancer increased by 15% from 29% to 34% for all biopsies submitted during the study period. For the age group 50 to 59 years, a 45% increase occurred in the detection of prostate cancer from a baseline of approximately 11% in 1995 to greater than 16% in 2001. For the age group 70 to 79 years, the detection of prostate cancer decreased from a baseline of 41% in 1995 to 36% in 2001. Conclusions. The increase in prostate cancer diagnosis among younger men in the United States has been significant. The increase is likely multifactorial and may be attributable to the impact of PSA and prostate cancer screening efforts. This has led to a greater number of younger men undergoing evaluation for prostate cancer. Thus, a heightened awareness regarding the diagnosis of prostate cancer among younger men is needed.

UR - http://www.scopus.com/inward/record.url?scp=0344234465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344234465&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(03)00782-9

DO - 10.1016/S0090-4295(03)00782-9

M3 - Article

VL - 62

SP - 1045

EP - 1049

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -